NCT00262587

Elite Sport and Development of Asthma

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Bispebjerg Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 35 Years
• Healthy volunteers: Accepted

Summary

International studies have shown that elite athletes have a high prevalence of respiratory symptoms and asthma as compared to normal subjects. It is unclear whether the increased prevalence of asthma in elite athletes reflects "traditional asthma" or whether it is a special form of "sports asthma". The treatment of elite athletes with asthma seems to vary widely, and only a few studies have focused on the treatment of elite athletes with asthma. Further knowledge of the pathogenesis of sports asthma would lead to a greater understanding and better treatment of the condition. This study will investigate the type of airway inflammation in elite athletes and examine the effect of treatment with inhaled steroids in combination with long-acting beta-agonists versus placebo in the same group.

Conditions

• Asthma

Interventions

Type	Name	Description
DRUG	Seretide	Combination of inhaled corticosteroids (250 microgr) and inhaled long-acting beta2-agonists (25 microgr)
DRUG	Placebo	Inhaled sugar powder in a placebo inhaler

Timeline

• Start date: 2005-09-01
• Primary completion: 2008-12-01
• Completion: 2008-12-01
• First posted: 2005-12-07
• Last updated: 2012-05-16

Locations

1 site across 1 country: Denmark